Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas - Wikidata - thesis-toulmin - TriplyDB

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

http://www.wikidata.org/entity/Q37435376

about

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Recent concepts of ovarian carcinogenesis: type I and type II G-DOC Plus - an integrative bioinformatics platform for precision medicine.A novel KCNQ4 mutation and a private IMMP2L-DOCK4 duplication segregating with nonsyndromic hearing loss in a Brazilian family Single-nucleotide polymorphisms among microRNA: big effects on cancer.Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.Frequent downregulation of miR-34 family in human ovarian cancers.Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma Whole exome sequence analysis of serous borderline tumors of the ovary.KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma Ovarian cancer development and metastasis.Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.Activation of the MEK-S6 pathway in high-grade ovarian cancers.TAGCNA: a method to identify significant consensus events of copy number alterations in cancer.Genome-wide identification of significant aberrations in cancer genome.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.Comparative analysis of methods for identifying recurrent copy number alterations in cancer.Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach.Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients miR-34 - a microRNA replacement therapy is headed to the clinic.Somatic mutations of PPP2R1A in ovarian and uterine carcinomas Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma Modeling high-grade serous ovarian carcinogenesis from the fallopian tube Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome G-DOC: a systems medicine platform for personalized oncology The new face of ovarian cancer modeling: better prospects for detection and treatment.Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells.Ovarian Cancer Is an Imported Disease: Fact or Fiction?Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

P2860

Q26822545-F333986A-5235-4440-AB7C-0FBF62559CC9 Q27009487-E5A184E9-4BFC-4335-B384-5BD5E4F2A38B Q27319225-3ED33E4E-364D-48AA-B47C-1D8766D0D4AF Q30385875-4FFBD0FA-3B8A-4E76-AA59-0DF5A75A9840 Q33579702-C0F1F3B7-2630-41CC-9487-59378A821585 Q33598001-BC74C890-3F55-45C3-A946-C2E80585B194 Q33658229-D37172E7-4090-4B02-9D5D-DBBDF64F39B4 Q33735170-97035A98-1589-4877-9557-A817C0EC1FD6 Q33739695-81B9389A-4659-4B1A-8777-F4582ED29877 Q33767047-04C6F05D-B02E-4D36-9D22-8EE438CFC1DF Q33853093-E630CC54-AE7B-485D-9BC5-4C4B25DB5125 Q33893010-4FDAB056-6381-4DB6-94F3-C5F3AE5F4BE4 Q34086819-605C8355-52CA-414A-A7F4-314B2324EDC8 Q34097804-DCDEC659-BD3A-45BB-9489-20150B8B8E35 Q34162272-63F4C26A-BB2F-4235-A8E3-4F7D0B49F5A4 Q34166257-B2199DE4-DB07-4F16-8393-84622DAF6FB5 Q34339010-38B4B319-7A99-4036-87F2-723889E5ABCB Q34345632-83F865B4-3F6D-4505-AF4A-49D84ACC3E82 Q34354428-52FC998C-D9B1-405E-9826-B474F9385A07 Q34361640-2D40EE7C-1789-4E3B-B9CB-49DC17BD82FA Q34393919-AB7BA4A7-9434-48CF-A924-66033608CD31 Q34534035-D09CF818-8411-4B5D-AC5F-A428A1C63D91 Q34565756-F192A94D-7570-4C9F-8FDD-D87CD3768FBC Q34626018-068054DD-1073-40C6-9776-15E595756C30 Q34640230-CDE80529-D7F9-4145-AFF5-073E259915E5 Q34805570-AF84B03C-09C0-4FCA-A0EC-E2369FBFB8C4 Q34887528-5B44C11C-9FBD-467F-81BF-162922652863 Q34899256-BC469842-BE66-4C3E-AC6D-8EA66B4D00AC Q34938333-74ADD5F5-1996-422B-8A62-B174BA9DB6D1 Q34998994-F44036C9-07AF-4244-B65A-5D442C4B1617 Q35032994-E55A5E17-3EBE-4815-A26B-29350F7353BC Q35041937-50B028BA-F4E8-4A63-9960-32242595E851 Q35060446-11420140-F63A-4DC5-9FB6-7A3D518EDBED Q35190585-BD7B2E8C-F4AC-491D-8143-0E1226A6AA6D Q35238047-9E435A57-8962-4C09-9872-0D3E64DCB0BE Q35507860-B38ABE9C-F126-4098-A036-5D8A3539D5FD Q35598807-AB48BF26-491C-4876-89FD-6DA026DBFB48 Q35878320-FB48B935-59FF-46E6-89E0-80B5F7BA1F73 Q35924210-2C79692F-CC0B-4DA6-A4B8-858CA9C29FF9 Q35947034-5BB8377A-2E79-4A8F-BAD6-5D209BD899EE

P2860

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

http://www.wikidata.org/entity/Q37435376

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analysis of DNA copy number al ...... rade and high-grade carcinomas

@en

Analysis of DNA copy number al ...... ade and high-grade carcinomas.

@nl

type

label

Analysis of DNA copy number al ...... rade and high-grade carcinomas

@en

Analysis of DNA copy number al ...... ade and high-grade carcinomas.

@nl

prefLabel

Analysis of DNA copy number al ...... rade and high-grade carcinomas

@en

Analysis of DNA copy number al ...... ade and high-grade carcinomas.

@nl

P1433

Q37435376-1E8FE50F-7EAD-48E5-A953-D474415CD5EE

P1476

Q37435376-A57ADDC6-EB88-4270-AF35-AB3B5BD87E01

P2093

Q37435376-11B0BC01-502F-4284-9385-477D2E699F09

Q37435376-173A4723-1D4F-4035-B21B-B3392091FC46

Q37435376-2EDE96E3-6292-4B84-947F-0E36DEDDEA75

Q37435376-7653BFBB-C882-447E-9C3E-794B5050C717

Q37435376-77974C61-AFC9-4459-8611-14F3B6EB6EE3

Q37435376-8B5BDE7B-1CB3-499E-8585-2304C1297915

Q37435376-94A9373C-5745-49C8-BC3F-3BB5FA666E6C

Q37435376-B2BD3022-6870-46D3-A041-F204B00753A7

Q37435376-C3CF4744-A40C-4A0D-B19D-0A6E65EEA26A

Q37435376-DC8B95E6-DADA-404B-A0C0-7581B0F08FCE

P2860

Q37435376-029E4BE4-8F1E-459D-AF7B-157B6A3033C7

Q37435376-04F52E3D-8714-4D33-879F-7A86EFDBFBAC

Q37435376-08E4ECDF-6976-4968-8914-EB7DDC3975E4

Q37435376-08FBBE7D-E759-486F-BD95-683A0ECB2F0F

Q37435376-0D07D784-1686-4847-B5D5-2304C571A8FB

Q37435376-1CFB2168-A02A-4739-AE4C-76989FF8D564

Q37435376-243311C1-798F-44D7-A96E-6D8F9BEE1A8F

Q37435376-29ECC06F-4EC1-4C9C-92D8-5B8A0AE0D43C

Q37435376-3527B30E-75E5-4EAA-8606-A1ADCBCB5A26

Q37435376-3F8C7FCA-4105-4217-90CE-ADF4B7051356

P304

Q37435376-BB746ADA-DD32-43A4-9871-C201C6DC60EA

P31

Q37435376-B5B9AD3A-45D7-4A32-BDF3-BD1FF2474BEC

P356

Q37435376-4CD4AF26-3B57-42AD-8A32-2900ADBA493D

P407

Q37435376-012A5015-C4C8-4B1C-A8D3-D156B1245B61

P433

Q37435376-E01C96F7-A381-4CED-B867-222A1D8AFB3D

P478

Q37435376-5CDC61C0-C4E0-46CD-B05E-6A28CE2F0603

P577

Q37435376-820A720F-096F-4BC4-88D9-E5EF0D37A8D2

P5875

Q37435376-BB7330DD-FDA8-42C3-85A8-03BA17426A35

P698

Q37435376-7CF567FD-E98A-4E87-893C-C4CB9C394D06

P932

Q37435376-B42860BF-6600-48C4-A2BF-65EA501D3239

P356

0008-5472.CAN-08-3913

P1433

Cancer Research

P1476

Analysis of DNA copy number al ...... rade and high-grade carcinomas

@en

P2093

Bin Guan

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Kuan-Ting Kuo

http://www.w3.org/2001/XMLSchema#string

Natini Jinawath

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Tian-Li Wang

http://www.w3.org/2001/XMLSchema#string

Tsui-Lien Mao

http://www.w3.org/2001/XMLSchema#string

Xu Chen

http://www.w3.org/2001/XMLSchema#string

Yuanjian Feng

http://www.w3.org/2001/XMLSchema#string

Yue Wang

http://www.w3.org/2001/XMLSchema#string

P2860

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas

Cancer statistics, 2008

The genomic landscapes of human breast and colorectal cancers

DOCK4, a GTPase activator, is disrupted during tumorigenesis

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

Apply innovative technologies to explore cancer genome

P304

4036-4042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3913

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24346076

http://www.w3.org/2001/XMLSchema#string

P698

19383911

http://www.w3.org/2001/XMLSchema#string

P932

2782554

http://www.w3.org/2001/XMLSchema#string